Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 83 member D (FAM83D) is a mitosis-associated scaffolding protein localized to the mitotic spindle, where it recruits protein kinase CK1α to ensure proper spindle positioning and normal cell division[5]. FAM83D binds kinesins, microtubules, and protein kinases, modulating key aspects of the cell cycle, particularly chromosome alignment and G1/S transition[3][5]. Overexpression is found in numerous cancers and is linked to tumorigenesis, progression, and poor prognosis, making it a candidate diagnostic/prognostic biomarker[1]. FAM83D influences mitogenic signaling pathways, including ERK1/2 and possibly MTOR, JUN, and MYC signaling through its effects on protein stability[3][5]. There are currently no drugs targeting FAM83D directly, and it is not classified as a traditional receptor, enzyme, or transporter[1][3][5].
Not applicable; no drugs are known to act directly on FAM83D.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 83 member D (FAM83D).